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Immunoglobulin G (IgG) responses to viruses are generally assumed to be T-cell dependent (TD). Recently,
however, polyomavirus (PyV) infection of T-cell-deficient (T-cell receptor b chain [TCR-b] 2/2 or TCR-b3d
2/2) mice was shown to elicit a protective, T-cell-independent (TI) antiviral IgM and IgG response. A
repetitive, highly organized antigenic structure common to many TI antigens is postulated to be important in
the induction of antibody responses in the absence of helper T cells. To test whether the repetitive structure
of viral antigens is essential and/or sufficient for the induction of TI antibodies, we compared the abilities of
three forms of PyV antigens to induce IgM and IgG responses in T-cell-deficient mice: soluble capsid antigens
(VP1), repetitive virus-like particles (VLPs), and live PyV. Immunization with each of the viral antigens
resulted in IgM production. VLPs and PyV elicited 10-fold-higher IgM titers than VP1, indicating that the
highly organized, repetitive antigens are more efficient in IgM induction. Antigen-specific TI IgG responses,
however, were detected only in mice infected with live PyV, not in VP1- or VLP-immunized mice. These results
suggest that the highly organized, repetitive nature of the viral antigens is insufficient to account for their
ability to elicit TI IgG response and that signals generated by live-virus infection may be essential for the switch
to IgG production in the absence of T cells. Germinal centers were not observed in T-cell-deficient PyV-infected
mice, indicating that the germinal center pathway of B-cell differentiation is TD even in the context of a virus
infection.
Although cognate T-cell–B-cell cooperation is essential for
T-cell-dependent (TD) humoral immunity, antibody (immuno-
globulin M [IgM] and IgG) responses to a variety of antigens
in T-cell-deficient mice (14, 15, 17, 26) indicate that alterna-
tive, T-cell-independent (TI) mechanisms of B-cell activation,
differentiation, and isotype switching also operate in vivo. The
nature of these mechanisms and the essential characteristics of
the antigens which activate the TI pathways in vivo, however,
are not known. Many TI antigens (bacterial polysaccharides,
polymerized flagellin, etc.) have a highly organized, repetitive
antigen structure, which is thought to be essential for their
ability to induce antibody responses in the absence of T-cell
help. The repeating, identical epitopes can extensively cross-
link the B-cell receptor, enabling these antigens to deliver
strong activating signals to the B cells. The fact that both in
vitro and in vivo B cells respond differently to the same anti-
genic epitope when it is presented in a nonrepetitive versus a
highly organized, repetitive form (2, 21) supports this idea. It
has also been suggested that there is a correlation between the
repetitive structure of certain viruses and their ability to act as
TI antigens (3, 4).
Polyomavirus (PyV) infection of ab T-cell- or ab and gd
T-cell-deficient mice induces a TI IgM and IgG response,
which provides resistance to the infection. T-cell-deficient mice
survive PyV infection, whereas SCID mice have 100% acute
mortality (23, 24). Thus, PyV can effectively induce TI isotype
switch in vivo. In this study, PyV-infected T-cell-deficient mice
were used as a model to investigate the TI antiviral IgG re-
sponses and to analyze what role the nature of the antigen has
in TI IgM and IgG induction. Comparing the abilities of sol-
uble capsid proteins (VP1), repetitive virus-like particles
(VLPs), and live PyV to induce TI antibodies, we showed that
IgG responses, which require TI isotype switch, were elicited
only by infection with live virus, not by immunization with VP1
or VLPs.
MATERIALS AND METHODS
Mice and immunizations. C57BL/6, CBA, and T-cell receptor b chain
(TCR-b) 2/2 and TCR-b3d 2/2 mice on a C57BL background were obtained
from the Jackson Laboratory (Bar Harbor, Maine). Mice were immunized in-
traperitoneally (i.p.) with 10 mg of purified VP1 of PyV strain RA produced by
recombinant baculovirus (20) or with the same amount of recombinant VP1
protein assembled into VLPs in insect cultures (16). Infection with highly puri-
fied PyV strain RA (8) was done i.p., using 7 3 105, 7 3 106, or 7 3 107
PFU/mouse; in some experiments, unpurified PyV strain A2 was used.
VP1-specific ELISAs. To measure PyV capsid protein-specific antibody pro-
duction in enzyme-linked immunosorbent assays (ELISAs), 96-well plates were
coated with recombinant VP1 protein produced in Escherichia coli (11) (0.03
mg/well). The serum samples were tested in duplicate. Biotinylated horse anti-
mouse IgG and goat anti-mouse IgG and goat anti-mouse IgM plus streptavidin-
horseradish peroxidase (HRP) (Vector Laboratories Inc., Burlingame, Calif.)
were used to measure IgM and IgG, respectively. To detect IgG isotypes a
Southern Biotech (Birmingham, Ala.) isotyping kit and HRP-labeled rat anti-
mouse IgG2a from Pharmingen (San Diego, Calif.) were used. 3,39,5,59-Tetra-
methyl-benzidine tablets (Sigma, St. Louis, Mo.) were used as the substrate to
develop the enzyme reaction. Plates were read at an optical density of 450 nm
(OD450) by a THERMOMAX plate reader and SoftMax 2.3 software (Molecular
Devices Corp., Menlo Park, Calif.). The VP1 specificity of the ELISAs was tested
with wells coated with proteins (0.03 mg/well) derived from an E. coli lysate
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purified the same way as the recombinant VP1 protein. None of the serum
samples tested gave OD readings above the background with this control antigen.
GC staining. Frozen, OCT-embedded spleen sections were fixed and stained
with HRP-peanut agglutinin (PNA) (Vector Laboratories) to visualize germinal
centers (GC) and counterstained with hematoxylin.
RESULTS
Magnitude and isotype profile of TI IgG response to PyV in
T-cell-deficient mice. The magnitude of virus-specific TI IgG
production in PyV-infected TCR-b 2/2 and TCR-b3d 2/2
mice was evaluated by measuring PyV major capsid protein
(VP1)-specific IgG endpoint titers in ELISAs. On day 14 fol-
lowing i.p. infection with 7 3 106 PFU of purified PyV strain
RA, TCR-b 2/2 and TCR-b3d 2/2 mice had VP1-specific
serum IgG titers of 1.6 3 104, which was 1 log lower than the
IgG values detected in wild-type C57BL/6 mice (1.6 3 105)
(Fig. 1A and B). With another PyV strain, A2, the virus-
specific IgG levels in T-cell-deficient mice were also ;10% of
those measured in serum samples of immunocompetent mice
(Fig. 1C). Analysis of the isotype distribution of the virus-
specific IgG indicated that all four IgG subclasses were in-
duced by PyV infection in wild-type C57BL/6 mice, with IgG2a
and IgG2b being predominant. In TCR-b3d 2/2 mice, no
measurable VP1-specific IgG1 was observed, suggesting a T-
cell dependence for the generation of this isotype (Fig. 2). In
these T-cell-deficient mice with a C57BL/6 background, IgG2b
was the predominant virus-specific IgG subclass, and various
amounts of IgG2a and IgG3 were also consistently detected.
Interestingly, TCR-b 2/2 and TCR-b3d 2/2 mice with
129 3 C57BL background produced predominantly IgG2a in
response to PyV infection (data not shown). TCR-b 2/2 and
TCR-b3d 2/2 mice did not show reproducible differences in
the magnitude of VP1-specific IgG production, suggesting that
gd T cells do not significantly influence TI antibody responses
to PyV (Fig. 1C and 3).
TI IgM responses to viral capsomeres, VLPs, and PyV. PyV
is a nonenveloped icosahedral DNA virus. The major capsid
protein, VP1, forms pentameric capsomers, and 72 capsomeres
form the viral capsid (22). Because several known TI antigens
have a highly organized, repetitive antigenic structure, it has
been hypothesized that the structural repetitiveness is an es-
sential characteristic which enables viruses to act as TI antigens
(3, 4). The repetitive structure may function by cross-linking
the B-cell receptors, thus providing signals activating antibody
production.
To test whether the repetitive structure of PyV capsid is
essential and/or sufficient for the induction of TI IgM and IgG
antibody responses in vivo, three forms of the PyV VP1 antigen
were used to immunize T-cell-deficient mice. Purified pentam-
eric VP1 capsomeres were used as soluble protein antigens (11,
20). These capsomeres may randomly associate (19) but do not
form highly organized structures. The source of highly orga-
nized, repetitive viral antigens were VLPs, which are empty
viral capsids assembled in insect cell cultures after expression
of the VP1 protein by using a recombinant baculovirus vector
(16). The VLPs used in the experiments were morphologically
intact judged by electron microscopy. Purified PyV virions
were used as live viral antigens (8). The amount of protein
antigens (VP1 and VLP) used in these studies was 10 mg/
mouse i.p., an antigen dose equivalent to 70 hemagglutination
units (HAU) or 7 3 107 PFU of PyV. Live-virus infections
were performed with highly purified PyV strain RA given i.p.
in three different doses: 70, 7, and 0.7 HAU, corresponding to
;7 3 107, 7 3 106, and 7 3 105 PFU, respectively. VP1-specific
IgM and IgG responses to the three forms of antigens were
determined.
The VP1-specific IgM response peaked on day 4 in both
wild-type C57BL/6 and TCR-b3d 2/2 mice (Fig. 4A). On day
4, VP1-immunized immunocompetent and T-cell-deficient
mice both had a low but measurable level of VP1-specific IgM.
Both strains of mice, however, secreted significantly (10-fold)
higher levels of IgM in response to the repetitive antigen, VLP
(Fig. 4B and C). Infection with live, replicating PyV (7 3 106
and 7 3 105 PFU) led to two- to eightfold further increases in
peak virus-specific IgM levels compared to that for VLP im-
munization. These results show that the IgM responses in-
duced by viral proteins or live virus in the absence of T cells are
similar in magnitude to the IgM production observed in im-
munocompetent mice, suggesting that the early IgM response
is TI even in wild-type mice. The data also support the hypoth-
esis that structural repetitiveness enhances the efficiency of TI
FIG. 1. Magnitude of IgG response to PyV in immunocompetent and T-cell-
deficient mice. Shown are PyV VP1-specific serum IgG titers on day 14 postin-
fection. In experiments 1 and 2, the IgG titers of pooled serum samples (n 5 3)
from C57BL/6, CBA, TCR-b 2/2, and TCR-b3d 2/2 mice infected i.p. with
7 3 106 PFU of purified PyV strain RA were determined by VP1-specific
ELISAs and expressed as the reciprocal log10 endpoint dilutions giving absor-
bance values at 450 nm above the background. Experiment 3 shows data ob-
tained with mice infected with another PyV strain, A2. Pooled blood samples
from C57BL/6 and TCR-b 2/2 mice (n 5 6) and three individual samples from
TCR-b3d 2/2 mice were tested.
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IgM induction (3, 4), consistent with similar findings for mice
immunized with different forms of the vesicular stomatitis virus
glycoprotein (1, 2, 7).
TI IgG responses are elicited by virus infection but not by
immunization with viral capsomeres or VLPs. IgG responses
to PyV were detected from day 7 in PyV-infected C57BL/6 and
TCR-b3d 2/2 mice, and the VP1-specific IgG levels progres-
sively increased until day 21, when the experiment was termi-
nated (Fig. 5). In the absence of T cells (ab or ab and gd),
neither the VP1 capsomeres nor the VLPs induced IgG pro-
duction in T-cell-deficient mice (Fig. 5 and 6). In experiment 1,
on day 14 postinfection the VP1-specific IgG endpoint titers
were 104 in both TCR-b 2/2 and TCR-b3d 2/2 PyV-in-
fected mice. T-cell-deficient mice immunized with viral pro-
teins did not have detectable IgG above 1:100 serum dilution
(Fig. 6). In experiment 2, on day 21 after administration of
antigens in wild-type C57BL/6 mice, both capsomeres and
VLPs induced IgG responses with 3.2 3 103 and 1.2 3 104
endpoint titers, respectively. PyV-infected C57BL/6 mice had
an IgG titer of 8 3 105 on day 21, whereas TCR-b3d 2/2 mice
had a titer of 4 3 104, consistent with findings shown previously
(Fig. 1 and 6). No VP1-specific IgG was detected, however, in
T-cell-deficient mice immunized with VP1 proteins or VLPs
(Fig. 6). These results strongly suggest that the highly orga-
nized repetitive antigen structure, which VLPs possess simi-
larly to live virus, is not sufficient for the induction of a TI IgG
response. We conclude that other signals generated in the
context of live virus infection may be required for a TI isotype
switch.
Simultaneous infection of VLP-immunized TCR-b3d 2/2
mice with lymphocytic choriomeningitis virus (LCMV) did not
result in inducing VP1-specific IgG production. Serum samples
from all four mice on day 14 following infection with 5 3 104
PFU of LCMV and immunization with 70 HAU of VLPs i.p.
had VP1-specific IgG levels below the background of detection
in 1:100 dilution. Because LCMV infection can itself elicit
antiviral TI IgG responses (5), this result suggests that systemic
elevation of cytokines or activation of certain cell types in-
duced by the virus infections is not sufficient to help the effi-
cient TI isotype switch and argues for the importance of local
signals.
Lack of GC formation in PyV-infected T-cell-deficient mice.
In the course of a primary antibody response to TD antigens,
B cells follow one of two distinct pathways of differentiation.
They differentiated into antibody-secreting plasma cells, or
they migrate to the GC, where B cells proliferate, undergo
affinity maturation, and enter the B-cell memory pool (9, 12,
25). T-cell–B-cell interactions were shown to be essential for
the GC induction in mice immunized with protein antigens (6,
10), and classical TI antigens typically do not induce GC de-
velopment (17).
To test whether the GC pathway of B-cell differentiation
requires T-cell-derived signals in the course of a virus infec-
tion, we tested GC formation in PyV-infected T-cell-deficient
mice. GC B cells express a surface receptor for the lectin PNA,
and this allows for the identification of GC (25). Frozen sec-
tions of spleens from day 14 PyV-infected TCR-b 2/2 and
TCR-b3d 2/2 as well as from C57BL/6 mice were analyzed
for the presence of GC by immunohistochemistry. The forma-
tion of typical GC was not detectable in TCR-b 2/2 (Fig. 7B)
and TCR-bd 2/2 (data not shown) mice, although small
groups of weakly PNA-staining cells were seen in a fraction of
the animals. The spleen sections from C57BL/6 mice exhibited
numerous strongly PNA-staining areas characteristic of GC
formation (Fig. 7A). These results suggest that the develop-
ment of GC is TD even in the context of a virus infection.
FIG. 2. Isotype distribution of VP1-specific IgG in immunocompetent and T-cell-deficient PyV-infected mice. VP1 antigen- and isotype-specific ELISAs were
performed with pooled sera from C57BL/6 (n 5 5) and TCR-b3d 2/2 (n 5 5) mice in 1:50 dilution. The serum samples were taken on day 21 following i.p. infection
with PyV strain A2. The absorbance values of serum samples from uninfected mice were 0.048 to 0.06.
FIG. 3. VP1-specific IgG response to VLPs and PyV in TCR-b 2/2 and
TCR-b3d 2/2 mice. Serum samples obtained on day 14 following immunization
with 70 HAU of VLPs or 70 HAU of PyV were assayed in 1:100 serum dilution.
The absorbance (OD450) values are means and standard deviations (n 5 3 for
VLP-immunized TCR-b 2/2 and TCR-b3d 2/2 mice and PyV-infected
TCR-b 2/2 mice; n 5 2 for PyV-infected TCR-b3d 2/2 mice). The horizontal
line indicates the background absorbance obtained with uninfected mouse se-
rum.
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DISCUSSION
This study demonstrates that virus infection can elicit not
only IgM but also IgG responses without T-cell help, whereas
IgG production depends on T-cell help when the mice are
immunized with viral proteins. Repetitive antigens that
strongly cross-link B-cell receptors (bacterial polysaccharides,
haptenated polymers, and viruses) induce B-cell responses in
the absence of T-cell help. It has been postulated that the
highly structured organization of the epitope has a major role
in the induction of TI antibodies. Our results indicate that the
highly organized repetitive antigen structure of viruses indeed
increases the efficiency of TI IgM responses but is not sufficient
to induce antigen-specific IgG production. Therefore, we hy-
pothesize that for TI switch to IgG, B cells require signals
generated by live-virus infection.
Two observations suggest the importance of local signals in
the immediate vicinity of the responding B cell: (i) the magni-
tude of TI IgG responses did not change with changing the
infecting virus dose (from 7 3 105 to 7 3 107 PFU); and (ii)
administration of VLP and a heterogeneous live virus did not
result in a bystander induction of IgG response to the VLPs,
indicating that systemic elevation of cytokines or activation of
certain cell types is not the mechanism resulting in efficient
isotype switch. Based on these findings, we suggest that the
very high local antigen concentrations reached during infection
with live, replicating virus, which may be present at high levels
for a prolonged time, may contribute to the efficient induction
of TI responses. Another factor may be the local inflammatory
response accompanying virus infection, which results in the
activation of NK cells, macrophages, and dendritic cells and
FIG. 4. Virus-specific IgM production in immunocompetent and T-cell-defi-
cient mice in response to viral capsid proteins, VLPs, and live virus. (A) Time
course of VP1-specific IgM response. To compare the IgM levels in serum
samples obtained at different time points and assayed separately, the absorbance
values were converted to relative units. Absorbance of a positive control serum
(pooled serum from day 14 PyV-infected C57BL/6 mice, which was included in
every assay) was used as reference and considered 100 U. Data obtained with
serum samples (1:100 dilutions) from a C57BL/6 mouse (F) and a TCR-b3d
2/2 mouse (n) injected with 7 3 106 PFU of PyV (equivalent to 7 HAU) strain
RA and two TCR-b3d 2/2 mice (, ) infected with 7 3 105 PFU of PyV (0.7
HAU) strain RA are shown. (B) VP1-specific IgM titers on day 4 following
immunization expressed as reciprocal log10 of the endpoint dilutions giving
positive values in ELISAs. The data shown were obtained from pooled sera from
C57BL/6 mice immunized with 70 HAU of VP1 (n 5 2), 70 HAU of VLPs (n 5
3), or 7 HAU of PyV (n 5 1); TCR-b 2/2 mice injected with 70 HAU of VP1
(n 5 2) or 70 HAU of VLPs (n 5 3); and TCR-b3d 2/2 mice injected with 0.7
HAU of PyV (PyVlow; n 5 3) or 7 HAU of PyV (n 5 1). KO, knockout. (C)
VP1-specific IgM in 1:100 dilutions of sera obtained on day 7 following immu-
nization of T-cell-deficient mice. The OD450 values are means and standard
deviations for C57BL/6 mice immunized with 70 HAU of VP1 (n 5 2), 70 HAU
of VLPs) (n 5 3), or 7 HAU of PyV (n 5 1); TCR-b 2/2 mice injected with 70
HAU of VP1 (n 5 2) or 70 HAU of VLPs (n 5 3); and TCR-b3d 2/2 mice
injected with 0.7 HAU of PyV (PyVlow, n 5 3) or 7 HAU of PyV (n 5 1).
FIG. 5. Time course of VP1-specific IgG production in immunocompetent
and T-cell-deficient mice in response to VP1, VLPs, and PyV. The IgG response,
expressed in relative units, was calculated as described in the legend to Fig. 4.
Each curve represents data obtained by sequential bleeding of a mouse immu-
nized with 7 HAU of PyV (F), 0.7 HAU of PyV ( ), 70 HAU of VLPs (n), or
70 HAU of VP1 (). KO, knockout.
°
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the induction of a variety of cytokines. In this model, the
infectious nature of the antigen would be indicated by the
structure and the high local concentration, together with sig-
nals from the innate immune system, and the sum of these
signals would trigger B-cell differentiation and isotype switch
as well as IgM and IgG production even in the absence of
T-cell help. These mechanisms would allow the generation of
protective immunity against microbial pathogens even in an
organism with impaired T-cell functions but would still safe-
guard against autoimmunity.
The antiviral IgG isotypes produced in PyV-infected TCR-b
2/2 and TCR-b3d 2/2 mice were predominantly IgG2b,
with various amounts of IgG2a and IgG3 also synthesized. No
virus-specific IgG1 was detected in these mice, however, sug-
gesting that the synthesis of IgG1 depends on ab T-cell help.
This finding is consistent with a report describing antiviral
IgG2a, IgG2b, and IgG3 responses, but no IgG1 production, in
LCMV-infected CD40L 2/2 mice, which are deficient in a
crucial component of T-cell help (27).
Isotype switching occurs in the periarteriolar lymphoid sheaths
and in the GC. GC are also the sites associated with affinity
maturation and B-cell memory development (9). The lack of
typical GC in the spleen of PyV-infected T-cell-deficient mice
suggest that the GC pathway of B-cell differentiation is TD even
in the context of a virus infection. Affinity maturation may not be
absolutely dependent on the presence of GC, however, since in
lymphotoxin-a-deficient mice, which fail to develop GC, affinity
maturation of the antibody response following immunization with
a very high antigen dose was found (13). It will be interesting
therefore to test whether affinity maturation occurs in virus-in-
fected T-cell-deficient mice.
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FIG. 6. VP1-specific IgG titers on days 14 and 21 following immunization.
The IgG titers are expressed as log10 of reciprocal endpoint dilutions giving
positive values in ELISAs. In experiment 1, mean values and standard deviations
for groups of mice (three per group) immunized with 70 HAU of VP1, 70 HAU
of VLPs, or 7 HAU of PyV are shown. In experiment 2, pooled sera from
C57BL/6 mice immunized with 70 HAU of VP1 (n 5 2), 70 HAU of VLPs (n 5
3), or 7 HAU of PyV (n 5 1), TCR-b 2/2 mice injected with 70 HAU of VP1
(n 5 2) or 70 HAU of VLPs (n 5 3), and TCR-b3d 2/2 mice injected with 0.7
HAU of PyV (PyVlow; n 5 3) or 7 HAU of PyV (n 5 1) were tested. KO,
knockout.
FIG. 7. Lack of GC formation in PyV-infected TCR-b 2/2 and TCR-b3d
2/2 mice. Frozen sections of spleens were stained with HRP-PNA (brown) and
counterstained with hematoxylin (blue). (A) Spleen of a C57BL/6 mouse on day
12 postinfection. The PNA-staining areas indicate the presence of GC. (B)
Spleen of a TCR-b 2/2 mouse on day 12 postinfection.
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